Aetna

Pharmacy Is Dead
Pharmacy Is DeadThe CVS/Aetna deal won’t kill traditional pharmacy—it just shows that it’s already dead.
The CVS/Aetna Deal in 5 Quotes
The CVS/Aetna Deal in 5 QuotesNow that an official proposal has been announced, how are industry leaders responding?
Why Every Pharmacist Should Care About the CVS/Aetna Deal
Why Every Pharmacist Should Care About the CVS/Aetna DealEven if it doesn't happen, the deal says a lot about the current and future states of pharmacy.
Potential CVS-Aetna merger: Top 6 industry implicationsHealthcare executives identify how the industry could be affected if the Aetna-CVS merger goes through.
Potential CVS-Aetna merger: Key takeaways for health execsThe CVS Health-Aetna potential merger will have healthcare executives rethinking traditional industry competitors. Here’s why.
Opinion: Four reasons Texas Health Aetna joint venture is workingAs the industry moves to a value-based care model, here’s how one North Texas partnership is reinventing healthcare.
Pharmacists Pushing for DIR Relief
Pharmacists Pushing for DIR ReliefCommunity pharmacists fight against financial pressure for their survival.
How payer mega-merger failures affect healthcare consolidation trendsHere’s how experts say the blocked Aetna-Humana and Anthem-Cigna mergers will affect consolidation among payers and providers.
Value-based care takes over J.P. Morgan Healthcare Conference 2017Is the drive to value-based care really accelerating? What can be done amidst all of the uncertainty? Expert shares insights from the J.P. Morgan 35th Annual Healthcare Conference.
What health execs should watch: 2017 Supreme Court casesDecisions of the U.S. Supreme Court can have a huge impact on the healthcare industry. This year is no different.